CTRI/2023/07/055661尚未招募2 期
Improving health outcomes among older adults inIndia: effectiveness and implementability of a novel Comprehensive GeriatricAssessment based intervention - EHSAS pilot trial
Dr Jaya Singh Kshatri0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •We will include all permanent residents of the selected cluster who are 60 years or above of age as participants for the trial.
- •The participants should be able to provide written informed consent and agree to follow up for 24 months
排除标准
- •We will exclude those with severe cognitive impairment (as assessed by the Dementia assessment rapid test- DART), those unable to comprehend/communicate, seriously ill/bed ridden patients and those who plan to move out of the study site during the trial period.
研究者
相似试验
招募中
不适用
Improving health and well-being of elderly patients through nurse-led discharge plan and follow-up care: a Randomised Controlled TrialWell-being in the elderlySLCTR/2017/011niversity of Sri Jayewardenepura
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-BESaarland University388
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.Patients with first relapse or progression of aggressive Non-Hodgkin’s Lymphoma who are not eligible neither for autologous nor allogeneic stem cell transplantationMedDRA version: 22.0Level: PTClassification code 10029547Term: Non-Hodgkin's lymphomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2016-002272-27-ATSaarland University388
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible for high-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma in first Relapse or Progression by adding Nivolumab to a standard chemotherapy.EUCTR2016-002272-27-PTSaarland University388
进行中（未招募）
1 期
Improvement of Outcome in Elderly Patients or Patients not eligible forhigh-dose chemotherapy with Aggressive Non-Hodgkin Lymphoma infirst Relapse or Progression by adding Nivolumab to Gemcitabine,Oxaliplatin plus Rituximab in case of B-cell lymphoma.EUCTR2016-002272-27-PLSaarland University388